Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients
NCT07012759 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2026-03-05
Summary
This project aims to assess the expression levels of novel molecular markers identified through screening in clinical samples of malignant pleural effusion, to evaluate the feasibility and clinical utility of these markers as potential diagnostic genes for lung adenocarcinoma.
Conditions
- Biomarkers
- Lung Adenocarcinoma
- Pleural Effusion
Interventions
- OTHER
-
biomarkers
pleural effusion biomarkers in lung adenocarcinoma
Sponsors & Collaborators
-
Fu Jen Catholic University
lead OTHER
Principal Investigators
-
Ke-Yun Chao, PhD · Fu Jen Catholic University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-06-10
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Novel Pleural Fluid, Biopsy and Serum Biomarkers for the Investigation of Pleural Effusions
NCT03661801 ·Status: COMPLETED
-
Non Small Cell Lung Cancer Evaluation According to Pre-determined Drug-targeting Tumor Markers
NCT01141686 ·Status: COMPLETED
-
Gene Expression Profiling of Breast Cancer Cells Predict the Response of Malignant Pleural Effusion
NCT01256801 ·Status: COMPLETED
-
An Observational Study on the Assessment of Lung Cancer Using Liquid Biopsy for Collecting miRNA Expression Profile and DNA Methylation Biomarkers.
NCT07182214 ·Status: RECRUITING
-
Monitoring the Changes of Tumor-related Biomarkers Before and After Pulmonary Nodule Biopsy.
NCT03397355 ·Status: UNKNOWN
-
A Comprehensive Evaluation of Circulating Tumor DNA and Circulating Tumor Cells as a Predictive Marker in Lung Cancer
NCT04254497 ·Status: COMPLETED
-
Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer
NCT00897143 ·Status: WITHDRAWN
-
Developing Novel Circulating Epigenetic Biomarkers for Early Detection of Lung Cancer
NCT04814407 ·Status: RECRUITING
-
Biomarkers for Diagnosis of Lung Cancer
NCT02050100 ·Status: COMPLETED
-
Molecular Profiling of Metastatic Cancer in Pleural Effusion and Ascites
NCT01369992 ·Status: UNKNOWN
-
Comparision of Various Biomarkers Between Peripheral and Pulmonary Blood
NCT05587114 ·Status: RECRUITING
-
Prognostic Factors on Malignant Pleural Effusion
NCT03276715 ·Status: COMPLETED
-
Biomarkers in Tissue and Blood Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
NCT01139944 ·Status: COMPLETED
-
Biomarker Discovery in Lung Cancer - Malaysia
NCT06504927 ·Status: RECRUITING
-
Risk Stratification of Patients Using the Lung Cancer Biomarker Panel in China
NCT01928836 ·Status: COMPLETED
-
A Study of Predictive and Prognostic Markers in Patients With Non-small Cell Lung Cancer
NCT00958555 ·Status: UNKNOWN
-
Multicenter Observational Study of Advanced Non-small Cell Lung Cancer With Malignant Pleural Effusion
NCT04263688 ·Status: UNKNOWN
-
Pyruvate Kinase Isoform M2 (PKM2) as a Possible Biomarker for Cancer
NCT01130584 ·Status: COMPLETED
-
DNA Methylation Biomarkers to Predict Survival After Surgery for Lung Adenocarcinoma
NCT06477211 ·Status: COMPLETED
-
Longitudinal Follow up of Patients With Pleural Effusion
NCT04670562 ·Status: RECRUITING
-
Genotyping of Non-small Cell Lung Cancer
NCT02002117 ·Status: UNKNOWN
-
Serum Exosomal Long Noncoding RNAs as Potential Biomarkers for Lung Cancer Diagnosis
NCT03830619 ·Status: COMPLETED
-
To Establish a Molecular Typing System for Early Diagnosis of Lung Cancer
NCT05432128 ·Status: RECRUITING
-
Prediction of Immunotherapeutic Effect of Advanced Non-small Cell Lung Cancer
NCT04427475 ·Status: UNKNOWN ·Phase: NA
-
Correlation Between EGFR Mutation Using cfDNAs and Circulating Tumor Cells in Patients With NSCLC
NCT02422628 ·Status: UNKNOWN